Attrition in metastatic breast cancer: a metric to be reported in randomised clinical trials?

Lancet Oncol. 2020 Jan;21(1):21-24. doi: 10.1016/S1470-2045(19)30792-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / psychology
  • Breast Neoplasms / secondary
  • Female
  • Humans
  • Lost to Follow-Up*
  • Patient Dropouts / psychology*
  • Patient Dropouts / statistics & numerical data*
  • Randomized Controlled Trials as Topic